Register a trial

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT02657850




Registration number
NCT02657850
Ethics application status
Date submitted
11/01/2016
Date registered
18/01/2016

Titles & IDs
Public title
Head and Neck Cancer Treatment Related Dysphagia
Scientific title
Multi-Institution Longitudinal Evaluation of Head and Neck Cancer Treatment - Related Dysphagia
Secondary ID [1] 0 0
IRB00074509
Secondary ID [2] 0 0
J1670
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Head and Neck Cancer 0 0
Dysphagia 0 0
Condition category
Condition code
Cancer 0 0 0 0
Head and neck
Oral and Gastrointestinal 0 0 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Other interventions - non- head and neck self reporting
Other interventions - head neck self reporting
Other interventions - provider reporting

control cohort - study subject self-reporting - Participants who have another cancer (not head and neck cancer) and undergoing treatment will self-report their dysphagia symptoms.

study cohort - study subject self-reporting - Participants who have head and neck cancer and undergoing treatment will self-report their dysphagia symptoms.

study cohort - provider reporting - Participants who have head and neck cancer and undergoing treatment will have their dysphagia symptoms reported by the provider.


Other interventions: non- head and neck self reporting
non- head and neck patient self reports dysphagia symptoms

Other interventions: head neck self reporting
head and neck patient self reports dysphagia symptoms

Other interventions: provider reporting
provider reports on head and neck cancer patients' dysphagia symptoms
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Change in rate of dysphagia symptoms
Timepoint [1] 0 0
24 months
Secondary outcome [1] 0 0
Change in rate of dysphagia between non head and neck and head and neck patients
Timepoint [1] 0 0
24 months
Secondary outcome [2] 0 0
change in dysphagia across different patient treatments
Timepoint [2] 0 0
24 months
Secondary outcome [3] 0 0
change in dysphagia across different patient treatments
Timepoint [3] 0 0
24 months
Secondary outcome [4] 0 0
change in dysphagia across different patient treatments
Timepoint [4] 0 0
24 months
Secondary outcome [5] 0 0
change in dysphagia across different patient treatments
Timepoint [5] 0 0
24 months
Secondary outcome [6] 0 0
change in dysphagia across different patient treatments
Timepoint [6] 0 0
24 months
Secondary outcome [7] 0 0
change in rate of secondary treatment side effect
Timepoint [7] 0 0
24 months
Secondary outcome [8] 0 0
change in rate of secondary treatment side effect
Timepoint [8] 0 0
24 months
Secondary outcome [9] 0 0
change in rate of secondary treatment side effect
Timepoint [9] 0 0
24 months

Eligibility
Key inclusion criteria
Inclusion Criteria - Head and Neck Cancer Study Subjects:

1. Previously untreated head and neck cancer of any histology receiving treatment with curative oncologic intent regardless of the treatment modality.
2. Capable of providing informed consent.

Inclusion Criteria - Non-Head and Neck Cancer Study Subjects

1. Previously untreated cancer of any histology with no prior history of swallowing disorder and receiving radiation or concurrent chemoradiation or chemotherapy followed by radiation or concurrent chemoradiation.
2. Screening SSQ <234 prior to any cancer treatment.
3. Capable of providing informed consent.
Minimum age
18 Years
Maximum age
100 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Exclusion Criteria -

1. Potential study subjects who are unwilling or unable to be adherent to longitudinal assessment and follow-up. This will include potential study subjects who have poor performance status at the time of study enrollment evaluation.
2. Potential study subjects who have cognitive limitations / impairments that prevent a potential study subject's ability to provide self-reporting with the SSQ instrument and/or other data elements required as described in the study calendar.
3. Potential study subjects who have motor skill limitations that prevent a potential study subject's ability to provide self-reporting with the SSQ instrument and/or other data elements required as described in the study calendar.

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Withdrawn
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
9/06/2016
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
8/06/2017
Sample size
Target
Accrual to date
Final
0
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
University of New South Wales - St. George Hospital - Sydney
Recruitment postcode(s) [1] 0 0
- Sydney
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Arizona
Country [2] 0 0
United States of America
State/province [2] 0 0
Colorado
Country [3] 0 0
United States of America
State/province [3] 0 0
Minnesota
Country [4] 0 0
United States of America
State/province [4] 0 0
Missouri
Country [5] 0 0
United States of America
State/province [5] 0 0
New York
Country [6] 0 0
United States of America
State/province [6] 0 0
Washington
Country [7] 0 0
Canada
State/province [7] 0 0
Ontario
Country [8] 0 0
China
State/province [8] 0 0
Hong Kong

Funding & Sponsors
Primary sponsor type
Other
Name
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Harry Quon, M.D.
Address 0 0
The SKCCC at Johns Hopkins
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
What data in particular will be shared?
When will data be available (start and end dates)?
Available to whom?
Available for what types of analyses?
How or where can data be obtained?


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT02657850